Disclosures for "Central Nervous System Demyelination Associated With TNF-alpha Inhibitors: A 20-years Systematic Review and Meta-analysis "
-
Dr. Akram has nothing to disclose.
-
Dr. Aljarallah has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Aljarallah has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Aljarallah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Genzyme.